SOUTHERN BIOSYSTEMS INC has a total of 35 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Australia, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, machines and medical technology are MASTELLI S R L, VUKICEVIC SLOBODAN and HALSCION INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 6 | |
#4 | United States | 6 | |
#5 | Brazil | 2 | |
#6 | China | 2 | |
#7 | EPO (European Patent Office) | 2 | |
#8 | New Zealand | 2 | |
#9 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Machines | |
#3 | Medical technology | |
#4 | Organic fine chemistry | |
#5 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Tipton Arthur J | 30 |
#2 | Gibson John W | 17 |
#3 | Holl Richard J | 13 |
#4 | Burns Patrick J | 8 |
#5 | Sullivan Stacey A | 4 |
#6 | Middleton John G | 2 |
#7 | Tipton A J | 2 |
#8 | Meador Stacey | 2 |
#9 | Middleton John C | 2 |
#10 | Holl R J | 1 |
Publication | Filing date | Title |
---|---|---|
AU2006203112A1 | High viscosity liquid controlled delivery system as a device | |
WO03000156A1 | Zero-order prolonged release coaxial implants | |
AU5025300A | Compositions for controlled release of the hormone gnrh and its analogs | |
US6413536B1 | High viscosity liquid controlled delivery system and medical or surgical device | |
US6291013B1 | Emulsion-based processes for making microparticles | |
US6051558A | Compositions suitable for controlled release of the hormone GnRH and its analogs | |
US5968542A | High viscosity liquid controlled delivery system as a device | |
AU6273196A | High viscosity liquid controlled delivery system | |
US5747058A | High viscosity liquid controlled delivery system |